INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
16/03/2026
Voltar para busca
Dado oficial do USPTO
SYQE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
53
Atualização mais recente
17/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 44
Data de depósito
01/02/2017
Data de registro
09/04/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/07/2025
Última transação
17/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Tel-Aviv, IL
Examinador
STRUCK, ROBERT J
Localização atual
Historical data usage
Titulares e representantes
Titulares
Syqe Medical Limited
Syqe Medical Limited
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and medical preparations for use by inhalation for the treatment of central nervous system diseases and symptoms; plant extracts for medicalveterinary and pharmaceutical purposes for use by inhalation; processed medicinal plant components for use in an inhalation device for medical purposesmedicinal herb extracts; none of the foregoing containing cannabis
Classe 10
Inhalers and medical devices for pulmonary delivery of pharmaceuticalsinstruments and apparatus provided empty used for the inhalation of pharmaceuticals; inhalers and medical devices containing plant material for pulmonary deliveryinhalers for medical use sold empty; none of the foregoing for use with cannabis
Classe 44
Providing medical information in the field of ethnobotany; providing information pertaining to therapeutic botanical substances by means of an Internet website
Publicações
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
16/07/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
16/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14/07/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
22/05/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
08/04/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/05/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/08/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/08/2019
FIMP
FINAL DISPOSITION PROCESSED
03/08/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/07/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
09/04/2019
GPNX
NOTIFICATION PROCESSED BY IB
25/01/2019
PUBO
PUBLISHED FOR OPPOSITION
22/01/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/01/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/01/2019
NPUB
NOTICE OF PUBLICATION
02/01/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/12/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
30/11/2018
CNEA
EXAMINERS AMENDMENT MAILED
30/11/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/11/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/11/2018
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
03/10/2018
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/10/2018
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
20/09/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
20/09/2018
ATRV
ATTORNEY REVIEW COMPLETED
05/07/2018
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
11/06/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/06/2018
CNRT
NON-FINAL ACTION MAILED
18/05/2018
CNRT
NON-FINAL ACTION WRITTEN
17/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/04/2018
ALIE
ASSIGNED TO LIE
26/04/2018
NREV
NOTICE OF REVIVAL - MAILED
19/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/04/2018
PETG
PETITION TO REVIVE-GRANTED
19/04/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
19/04/2018
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
28/03/2018
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
28/03/2018
RFNT
REFUSAL PROCESSED BY IB
01/09/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/08/2017
RFRR
REFUSAL PROCESSED BY MPU
16/08/2017
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
16/08/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/08/2017
CNRT
NON-FINAL ACTION WRITTEN
14/08/2017
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/08/2017
MAFR
APPLICATION FILING RECEIPT MAILED
11/08/2017
DOCK
ASSIGNED TO EXAMINER
07/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/08/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SYQE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.